Kineret (anakinra) is an IL-1 receptor antagonist. This therapeutic drug is used for the treatment of patients with rheumatoid arthritis, NOMID, and DIRA. Many patients inquire about Kineret injection in India, but the therapy is not available in Indian pharmacies. Still, under the Named Patient Program (NPP), patients can access the medicine legally with physician support and proper import permits. This process ensures treatments for rare and immune-related conditions reach eligible patients in compliance with regulations. By bridging this access gap, the provision of NPP gives patients hope when no other therapy is available. For assistance with legal access to Kineret 100 mg injection, reach us at Call/WhatsApp: +91 93100 90915 | TOLL-FREE: 1800-889-1064.